UPDATE 1-Swedish drug company Sobi in talks on bid for company

STOCKHOLM, April 27 (Reuters) - Swedish Orphan Biovitrum , which specializes in selling medicines for rare diseases, said it had received a preliminary proposal for a bid on the firm, the latest company to be sucked into a whirl of deal-making in the healthcare sector.